Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4612883

COc1ccnc2c1ccc1c(OC)ccnc12.COc1ccnc2c1ccc1c(OC)ccnc12.Cl[Rh+]Cl.[Cl-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 3/20 0.47
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
HTR1A P08908 2/20 0.40
ADRA1D P25100 2/20 0.40
ADRA1A P35348 2/20 0.40
ADRA1B P35368 2/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
G6PD P11413 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 2/20 0.38
DOT1L Q8TEK3 1/20 0.37
GAK O14976 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185654 0.92 CCR1 (0.50) SLC40A1CCR1CCR5CCR8HTR1A
SCHEMBL8032037 0.82 CCR1 (0.69) SLC40A1CCR1CCR5CCR8HTR1A
Hydrochloric Acid SCHEMBL5931340 0.82 RELA (0.41) SLC40A1CCR1CCR5CCR8PDGFRB
SCHEMBL15195529 0.81 G6PD (0.44) SLC40A1HTR1AADRA1DADRA1AADRA1B
SCHEMBL13621091 0.81 SLC40A1 (0.42) SLC40A1CCR1CCR5CCR8HTR1A
SCHEMBL8140602 0.78 SLC40A1 (0.43) SLC40A1CCR1CCR5CCR8HTR1A
SCHEMBL30492645 0.78 CCR1 (0.62) SLC40A1CCR1CCR5CCR8PDGFRB
SCHEMBL10505657 0.78 CCR1 (0.62) SLC40A1CCR1CCR5CCR8PDGFRB
SCHEMBL14871760 0.77 HTR1A (0.53) SLC40A1HTR1AADRA1DADRA1AADRA1B
SCHEMBL9605472 0.77 CCR1 (0.45) SLC40A1CCR1CCR5CCR8HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546168-A4 PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT PURDUE RESEARCH FOUNDATION (US) 2008-03-12 EP disclosed
US-20060111335-A1 Photoactivated anti-viral and anti-cancer agent PURDUE RESEARCH FOUNDATION 2006-05-25 US disclosed
EP-1546168-A2 PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT PURDUE RESEARCH FOUNDATION (US) 2005-06-29 EP disclosed
WO-2004012667-A2 PHOTOACTIVATED ANTI-VIRAL AND ANTI-CANCER AGENT PURDUE RESEARCH FOUNDATION (US) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111335-A1 Photoactivated anti-viral and anti-cancer agent TP53, POLI, POLK SLC40A1 2479/4885CCR1 4643/4885CCR5 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.